Table 2 Patient characteristics based on Vitamin D levels
Study parameters | 25 (OH) Vitamin D | p-value | |
|---|---|---|---|
< 10 ng/mL | ≥ 10 ng/mL | ||
Age | 31.8 ± 9.3 | 35.5 ± 11.2 | 0.082 |
BMI (Kg/m2) | 24.8 ± 5.6 | 24.0 ± 3.1 | 0.335 |
Female sex | 18 (43.9%) | 14 (21.9%) | 0.017 |
Proteinuria (g/day) | 3.3 ± 2.0 | 3.0 ± 2.7 | 0.502 |
Hypertension | 25 (60.1%) | 40 (62.5%) | 0.875 |
eGFR (mL/min/1.73 m2), mean ± SD | 78.0 ± 37.1 | 68.4 ± 37.0 | 0.326 |
eGFR < 60 mL/min/1.73 m2 | 16 (39.0%) | 31 (48.4%) | 0.344 |
Haematuria | 18 (28.1%) | 29(70.7%) | 0.887 |
Serum albumin(g/dl), mean ± SD | 3.7 ± 0.9 | 4.1 ± 0.7 | 0.018 |
Serum albumin < 3.5 g/dL | 14 (34.1%) | 11 (17.2%) | 0.047 |
Use of ACE inhibitors | 38 (92.7%) | 54 (84.4%) | 0.242 |
Use of Immunosuppressants | 25 (60.1%) | 35 (54.7%) | 0.525 |
Renal disease progression (primary outcome) | 5(12.5%) | 6 (9.4%) | 0.614 |
Disease Remission at follow-up | 28(68.3%) | 42 (65.6%) | 0.777 |